v3.26.1
Related party transactions (Tables)
12 Months Ended
Mar. 31, 2026
Disclosure of transactions between related parties [abstract]  
Schedule of consolidated financial statements the related party transactions

 

   2026   2025   2024 
   USD   USD   USD 
             
Associates:               
Alps Globemedics               
Agent commission   105,050    196,531    120,189 
Management fee income   14,185    13,534    12,916 
                
Related party:               
Director               
Agent commission   13,333    45,590    18,102 
Management fee income   -    -    12,916 
Patent License Agreement *   -         707,028 
                         
Major shareholder                        
Sale of cellular therapy     32,783       13,042       -  

 

* During the financial year ended March 31, 2024, the Company entered into a Patent License Agreement with a director of the Company, wherein the director shall grant to the Company an exclusive, royalty-free and non-transferable right and license all the patents stated in the agreement.
Schedule of key management personnel

 Schedule of key management personnel

   2026   2025   2024 
   USD   USD   USD 
             
Fee   34,659    79,998    71,811 
Salaries and other emoluments   349,783    185,871    162,726 
Defined contribution plans   32,078    20,555    19,255 
                
Total   416,520    286,414    253,792